Skip to content

Hepato-duodenal Ligament Occlusion and Classic Technique in Liver Transplant

Hepato-duodenal Ligament Occlusion Versus Classic Technique During Recipient Hepatectomy in Liver Transplantation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04265157
Enrollment
50
Registered
2020-02-11
Start date
2020-03-31
Completion date
2022-09-30
Last updated
2020-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplant

Brief summary

Liver transplantation was historically associated with massive blood loss. Many factors have contributed to the decline in bleeding and transfusion in the past two decades including refinement of surgical techniques, anesthetics management and the use of point of care guided goal-directed hemostatic therapies. Increasing awareness of the adverse associations of allogenic transfusion has driven the quest for transfusion-free transplantation. Pre-operative management of preoperative anemia and targeted correction of coagulopathy is done to decrease blood transfusion. Liver transplantation is associated with the potential for massive operative blood loss, which has been recognized as one of the main causes of morbidity and mortality after liver transplantation. Therefore, a fine surgical procedure to reduce intraoperative hemorrhage is necessary for favorable outcomes of liver transplantation.

Interventions

PROCEDURESurgical technique surgical occlusion

Occlusion of hepatoduodenal ligament by clamp or occlusive bands

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* All patients undergoing Living Donor Liver Transplantation accepted according to hospital protocol * All patients with liver Cirrhosis who have Porto systemic collaterals based on ct angiography

Exclusion criteria

* Acute fulminant liver failure

Design outcomes

Primary

MeasureTime frame
The amount of intraoperative blood loss measure by Cubic Cm2 hours

Contacts

Primary ContactAhmed Elkoussy, Master
ahmdkoussy91@gmail.com+20010!17739

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026